A new study from the American College of Cardiology has found that the popular ketogenic or "keto" diet may contribute to higher levels of "bad cholesterol" and a twofold increase in the risk of heart attacks and strokes.
“Our study found that regular consumption of a self-reported diet low in carbohydrates and high in fat was associated with increased levels of LDL cholesterol— or “bad” cholesterol—and a higher risk of heart disease,” said Dr. Iulia Iatan, MD, PhD, lead author of the study and attending physician-scientist at the Healthy Heart Program Prevention Clinic in St. Paul’s Hospital.
“To our knowledge, our study is one of the first to examine the association between this type of dietary pattern and cardiovascular outcomes.”
The study points out that depriving the body of carbohydrates such as bread, pasta, and rice forces the body to break down fat for energy instead. This breakdown produces ketones in the liver, hence the name keto. Advocates for this type of diet suggest obtaining 60 to 80 percent of calories from fat.
By comparing this low-carbohydrate, high-fat (LCHF) diet with a more standard diet, the study found that it elevated levels of LDL cholesterol in some people, which is known to elevate the risk of heart disease.
Before starting this dietary pattern, they should consult a healthcare provider," Iatan said. "While on the diet, it is recommended they have their cholesterol levels monitored and should try to address other risk factors for heart disease or stroke, such as diabetes, high blood pressure, physical inactivity and smoking.”
The United States is approaching a record for the number of new daily coronavirus cases in the latest ominous sign of the disease’s grip on the nation.
A pilot study from New York University found that over the summer a quarter of NYC transit workers reported testing positive for the coronavirus and that 90 percent of them still had fears of contracting COVID-19 on the job.
Justice Department officials told The Associated Press that Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion.
Following psychedelic medicine company, COMPASS Pathways' IPO on the Nasdaq in September,.George Goldsmith, CEO and co-founder, joined Cheddar to discuss using psychedelics to innovate mental health treatments.
Katie Couric and the CEO of Susan G. Komen join Cheddar to discuss the importance of preventative healthcare and support resources during Breast Cancer Awareness Month.
Pharmaceutical company Merck has partnered with drone startup Volansi to make remote vaccine deliveries. Hannan Parvizian, Volansi founder and CEO, joined Cheddar to discuss the partnership and supplying rural areas with temperature-controlled vaccines..
The world's number of confirmed cases of COVID-19 has surpassed 40 million.
Nokia says it has been tapped by NASA to build the first cellular communications network on the moon.
Christian Gormsen, Eargo CEO, joined Cheddar to discuss the hearing aid company going public. and also about the path to expanding insurance coverage to include hearing aids.
Pfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well.
